Nimodipine is used for: Subarachnoid haemorrhage; Stroke prevention.
Recorded in the NepalDoc medicine catalog for Nimodipine.
AND USE Nimodipine oral solution is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I to V).
From the U.S. FDA-approved label for Nimodipine. Full label: DailyMed.
AND USE Nimodipine oral solution is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I to V).
From the U.S. FDA-approved label for Nimodipine. Full label: DailyMed.
Administer only enterally (e.g., oral, nasogastric tube, or gastric tube route). Do not administer intravenously or by other parenteral routes., Give one hour before a meal or two hours after a meal., Start dosing within 96 hours of the SAH., Recommended dose is 20 mL (60 mg) every 4 hours for 21 consecutive days., Nasogastric or Gastric Tube Administration: Administer 20 mL (60 mg) every 4 hours with an oral syringe. Refill syringe with 20 mL of 0.9% saline water solution; flush remaining contents from nasogastric or gastric tube into stomach., Patients with Cirrhosis: Reduce dosage to 10 mL (30 mg) every 4 hours.
Directions from the U.S. FDA-approved label for Nimodipine — your doctor or pharmacist may advise differently.
Hypotension: Monitor blood pressure., Patients with Cirrhosis: Higher risk of adverse reactions. Monitor blood pressure and pulse., CYP3A4 Strong Inhibitors: May significantly increase risk of hypotension. Concomitant use with nimodipine should generally be avoided., CYP3A4 Strong Inducers: May significantly reduce efficacy of nimodipine. Concomitant use with nimodipine should generally be avoided. 5.1 Hypotension Blood pressure should be carefully monitored during treatment with nimodipine.
Warnings and precautions excerpt from the U.S. FDA-approved label for Nimodipine — not a complete list. Talk to a pharmacist or doctor before use.
The safety and efficacy of nimodipine oral solution in the treatment of patients with SAH is based on adequate and well-controlled studies of nimodipine oral capsules in patients with SAH. Nimodipine oral solution has comparable bioavailability to nimodipine oral capsules. The following clinically significant adverse reaction appears in other sections of the labeling: Hypotension.
Excerpt from the U.S. FDA-approved label for Nimodipine — not a complete list. Talk to a pharmacist or doctor about side effects.
5 brands · 4 makers in the NepalDoc catalog — see the full Nimodipine guide →
Store between 20°C to 25°C (68°F to 77°F); Protect from light.
Storage information from the U.S. FDA-approved label for Nimodipine.
What is Nimocer?
Nimocer Syrup is a Nimodipine medicine made by Universal Formulation. It comes as Syrup.
What is Nimocer used for?
Nimodipine is used for Subarachnoid haemorrhage, Stroke prevention.
What is the generic name of Nimocer?
The generic name of Nimocer is Nimodipine.
Which brands of Nimodipine are available in Nepal?
5 brands of Nimodipine are listed in the NepalDoc catalog, from 4 makers — including Nimocer 30mg Tablet, Nimocer 10mg Tablet, Nimodip 30mg Tablet, Vasotop 30mg Tablet.
What are the side effects of Nimodipine?
The safety and efficacy of nimodipine oral solution in the treatment of patients with SAH is based on adequate and well-controlled studies of nimodipine oral capsules in patients with SAH. Nimodipine oral solution has comparable bioavailability to nimodipine oral capsules.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
